BCM
GMAB icon

Bourgeon Capital Management’s Genmab GMAB Stock Holding History

Bourgeon Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23
Closed -$733 – 210
2023
Q4 		$733 Buy
23
+4
+21% +$126 ﹤0.01% 346
2023
Q3 		$671 Buy
+19
New +$724 ﹤0.01% 327
2020
Q4 		– Sell
-41
Closed -$2K – 286
2020
Q3 		$2K Buy
+41
New +$1.48K ﹤0.01% 255

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bourgeon Capital Management's GMAB Position: Q1 2024 in Review

Bourgeon Capital Management sold out of Genmab (GMAB) in Q1 2024, closing a stake of 23 shares — an estimated $733 sold.

Bourgeon Capital Management first reported a position in GMAB in Q3 2020 and held it in 3 quarters. The position peaked at $2K in Q3 2020. 227 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.

  • Bourgeon Capital Management reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
  • Bourgeon Capital Management sold 23 Genmab shares in Q1 2024, an estimated $733.
  • Bourgeon Capital Management first reported a position in Genmab in Q3 2020 and held it in 3 quarters.
  • Bourgeon Capital Management's Genmab position peaked at $2K in Q3 2020.
  • 227 funds tracked by Wall St. Rank held Genmab as of Q1 2024.

Based on Bourgeon Capital Management's 13F filing for Q1 2024, filed 19 Apr 2024.